⌘K

Home/Filings/4/0001415889-17-000478

4//SEC Filing

Echo Therapeutics, Inc. 4

Accession 0001415889-17-000478

CIK 0001031927operating

View on SEC.gov Company Profile

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 12:38 PM ET

Size

5.1 KB

Accession

0001415889-17-000478

Insider Transaction Report

Form 4

Period: 2017-03-21

Echo Therapeutics, Inc.ECTE

GOLDBERG MICHAEL M

Director

Transactions

Award
Comon Stock, par value $.01
2017-03-21+25,000→ 39,500 total

Footnotes (1)

[F1]Restricted shares granted pursuant to the Issuer's 2008 Equity Incentive Plan which vested in full on the date of grant.

Documents

1 file

4
form4-03232017_090320.xmlPrimary

Issuer

Echo Therapeutics, Inc.

CIK 0001031927

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001031927

Filing Metadata

Form type: 4
Filed: Mar 22, 8:00 PM ET
Accepted: Mar 23, 12:38 PM ET
Size: 5.1 KB

View on SEC.gov